Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

Roger S McIntyre1 Department of Psychiatry, University of Toronto, Toronto, ON, Canada;2 Department of Pharmacology, University of Toronto, Toronto, ON, Canada;3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada;4 Institute of Medical Science, University of Toronto, Toronto, ON, CanadaCorrespondence[email protected]

Jinju Yoon3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada

Jeanette M Jerrell5 Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC, USA

Samantha S Liauw3 Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada

Pages 319-323 | Published online: 25 May 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

McIntyreRSSoczynskaJKWoldeyohannesHOMirandaAKonarskiJZAripiprazole: pharmacology and evidence in bipolar disorderExpert Opin Pharmacother2007871001100917472545
PubMed Web of Science ®Google Scholar
KinghornWAMcEvoyJPAripiprazole: pharmacology, efficacy, safety and tolerabilityExpert Rev Neurother20055329730715938662
PubMedGoogle Scholar
Bristol-Myers Squibb Company, Otsuka America Pharmaceutical Inc Aripirazole Product Monograph. Product Monograph. 10-1-2006
Google Scholar
DeLeonAPatelNCCrismonMLAripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerabilityClin Ther200426564966615220010
PubMed Web of Science ®Google Scholar
StahlSMDopamine system stabilizers, aripiprazole, and the next generation of antipsychotics, part 2: illustrating their mechanism of actionJ Clin Psychiatry2001621292392411780870
PubMed Web of Science ®Google Scholar
BowlesTMLevinGMAripiprazole: a new atypical antipsychotic drugAnn Pharmacother200337568769412708948
PubMed Web of Science ®Google Scholar
WoodMDScottCClarkeKAripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist propertiesEur J Pharmacol20065461–3889416925992
PubMed Web of Science ®Google Scholar
AiharaKShimadaJMiwaTThe novel antipsychotic aripiprazole is a partial agonist at short and long isoforms of D2 receptors linked to the regulation of adenylyl cyclase activity and prolactin releaseBrain Res200410031–291715019558
PubMed Web of Science ®Google Scholar
TadoriYMiwaTTottoriKAripiprazole’s low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychoticEur J Pharmacol20055151–3101915894311
PubMed Web of Science ®Google Scholar
KeckPEJrCalabreseJRMcQuadeRDA randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorderJ Clin Psychiatry200667462663716669728
PubMed Web of Science ®Google Scholar
ChessickCAAllenMHThaseMAzapirones for generalized anxiety disorderCochrane Database Syst Rev20063CD00611516856115
PubMed Web of Science ®Google Scholar
McIntyreRSKonarskiJZTolerability profiles of atypical antipsychotics in the treatment of bipolar disorderJ Clin Psychiatry200566Suppl 3283615762832
PubMed Web of Science ®Google Scholar
KeckPE26-Week Aripiprazole vs Placebo MaintenanceJ Clin Psychiatry200467462663716669728
PubMed Web of Science ®Google Scholar
BowdenCLCalabreseJRSachsGA placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorderArch Gen Psychiatry200360439240012695317
PubMed Web of Science ®Google Scholar
TohenMCalabreseJRSachsGSRandomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapineAm J Psychiatry2006163224725616449478
PubMed Web of Science ®Google Scholar
KeckPECalabreseJRMcIntyreRSAripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placeboJ Clin Psychiatry200768101480149117960961
PubMed Web of Science ®Google Scholar
KeckPEOrsulakPJCutlerAJAripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled studyJ Affect Disord20091121–3364918835043
PubMed Web of Science ®Google Scholar
VietaEOwenRBaudeletCMcQuadeRDSanchezRMarcusRNAssessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind studyCurr Med Res Opin20102661485149620429835
PubMed Web of Science ®Google Scholar
VietaET’joenCMcQuadeRDEfficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled studyAm J Psychiatry2008165101316132518381903
PubMed Web of Science ®Google Scholar
CarlsonBXSunWTimkoKEfficacy and safety of aripiprazole in combination with lamotrigine in a long-term maintenance study in manic or mixed subjects with bipolar I disorder (CN138-392)Proceedings of the 50th annual meeting of the New Clinical Drug Evaluation Unit (NCDEU)2010 Jun 14–17Boca Raton, Florida
Google Scholar
MarcusRKhanARollinLEfficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized studyBipolar Disord201113213314421443567
PubMed Web of Science ®Google Scholar
ThaseMEJonasAKhanAAripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studiesJ Clin Psychopharmacol2008281132018204335
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date